Comparative 30-day economic and clinical outcomes of platelet glycoprotein IIb/IIIa inhibitor use during elective percutaneous coronary intervention: Prairie ReoPro versus Integrilin Cost Evaluation (PRICE) Trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples